Other Income & Expense
Other Non-Cash Items
Gilead Sciences Other Non-Cash Items increased by 31.5% to -$183.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 101.1%, from -$91.00M to -$183.00M. Over 4 years (FY 2021 to FY 2025), Other Non-Cash Items shows an upward trend with a -5.3% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
First reportedQ1 2015
Last reportedQ1 2026May 7, 2026
Metric ID:
ms_other_noncash_income_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$328.00M | $0.00 | -$68.00M | -$182.00M | -$238.00M | -$126.00M | -$234.00M | -$63.00M | -$142.00M | -$55.00M | -$566.00M | -$119.00M | -$89.00M | -$86.00M | -$59.00M | -$91.00M | -$33.00M | -$89.00M | -$267.00M | -$183.00M |
| QoQ Change | — | +100.0% | — | -167.6% | -30.8% | +47.1% | -85.7% | +73.1% | -125.4% | +61.3% | -929.1% | +79.0% | +25.2% | +3.4% | +31.4% | -54.2% | +63.7% | -169.7% | -200.0% | +31.5% |
| YoY Change | — | — | — | — | +27.4% | — | -244.1% | +65.4% | +40.3% | +56.3% | -141.9% | -88.9% | +37.3% | -56.4% | +89.6% | +23.5% | +62.9% | -3.5% | -352.5% | -101.1% |
Range-$566.00M – $0.00
CAGR-11.6%
Avg YoY Growth-39.0%
Median YoY Growth+23.5%
Other Non-Cash Items at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's other non-cash items?
- Gilead Sciences (GILD) reported other non-cash items of -$183.00M in Q1 2026.
- How has Gilead Sciences's other non-cash items changed year-over-year?
- Gilead Sciences's other non-cash items decreased by 101.1% year-over-year, from -$91.00M to -$183.00M.
- What is the long-term trend for Gilead Sciences's other non-cash items?
- Over 4 years (2021 to 2025), Gilead Sciences's other non-cash items has grown at a -5.3% compound annual growth rate (CAGR), from -$597.00M to -$480.00M.